ANAB NASDAQ
AnaptysBio, Inc.
1W: -4.8%
1M: -13.1%
3M: -22.1%
YTD: +61.9%
1Y: +127.7%
3Y: +294.2%
5Y: +166.2%
$48.53
-0.10 (-0.21%)
Weekly Expected Move ±3.8%
$45
$47
$49
$50
$52
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$238M
Revenue
+92.9% YoY
$196M
Net Income
+247.6% YoY
$18M
Free Cash Flow
+114.1% YoY
109.8%
Gross Margin
243.6%
Op. Margin
668.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-1146.3%
ROA60.0%
ROIC466.0%
Valuation
P/E7.2
P/B134.2
EV/EBITDA27.7
Leverage
Debt/Equity25.47
Current Ratio5.61
Interest Cov.1.1x
Quality Scores
Piotroski F5/9
Altman Z4.22
Beneish M0.82